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We compare the adequacy of several titration procedures of oxygen flow in maintaining
SpO2 > 90% during the activities of daily life in patients with very severe COPD.
Thirty-one very severe COPD patients undergoing oxygen-therapy were recruited. Three
titration methods were randomly performed: (1) 6-min walking tests; (2) cycle-ergometer
constant work-rate tests at a load equivalent to 12 ml/min/kg of oxygen uptake; (3) one single
constant work-rate test at 40 W 12-h pulse-oximeter monitoring was performed on four consec-
utive days with the following oxygen flow during exercise: 1 l$min1 above the resting prescrip-
tion (NOTT guidelines) and those established by the titration procedures.
The time spent SpO2 < 90% was higher for the titration based on NOTT and walking tests than
for the oxygen flow established by the constant work-rate tests at 12 ml O2/min/kg
(22.1  18.7, 20.8  19.5 and 6.7  12.7%, respectively). As for the oxygen uptake-based titra-
tion, the simplified procedure (a single exercise test at 40 w) generates longer times spent
SpO2 < 90% and SpO2 < 85%, although it maintains a SpO2 > 90% for more 90% of the time.
In COPD patients, exercise oxygen flow titrations by NOTT guidelines or walking tests do not
allow a suitable oxygenation during the activities of daily life. Two more adequate alternative
methods, based on constant work-rate tests, are proposed.
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Oxygen flow in exercise 1545Introduction
Long-term oxygen therapy (LTOT) improves the survival of
hypoxemic patients with chronic obstructive pulmonary
disease (COPD).1,2 It is a well-documented finding that
LTOT also improves pulmonary hemodynamics, exercise
capacity, neuropsychological performance and
health-related quality of life in these patients.3,4
The therapeutic goal for LTOT is to maintain SpO2 > 90%
during rest, sleep and exertion.5 While there is broad
agreement as to who should receive LTOT based on resting
PaO2, there is little information on how clinicians should
choose the flow rates that the patients should receive during
their activities of daily living (ADL). Based on theNOTTstudy,2
the ATS/ERS guidelines for COPD management recommend
increasing the resting flow rate by 1 l$min1 during exercise.5
Again, the GOLD guidelines do not provide specific
recommendations about oxygen prescription during
exercise.6
However, previous studies have demonstrated that
using resting arterial blood gases to adjust the flow of
portable liquid oxygen does not adequately correct desa-
turation during ADL.4 In fact, the majority of clinicians
prefer to individualize oxygen during exercise by testing
each patient using several types of stress tests.7 Of these,
the most widely used is the 6-min walk test.7 It has been
shown that the walking test, as well as the other constant
work-rate tests, is more sensitive for detecting
desaturation than progressive incremental tests.8
However, there is no clear evidence that the saturation
level obtained in the 6-min walk test is an accurate
reflection of the level maintained during the hypoxemic
COPD patient’s ADL.9 Moreover, during the walk tests,
there are several factors that may be sources of variation
that affect SpO2 response
10,11 and prescription of oxygen
flow rate.
The best understanding of the daily physical activity
pattern of patients with very severe COPD12,13 allows to
identify the level of metabolic demand reached in their
ADL that produce oxygen desaturations.14,15 Therefore,
the titration of oxygen flow during exercise by a constant
work-rate test, at a load equivalent to the oxygen uptake
needed during the most frequent ADL, might be more
adequate for ensuring correct oxygenation. In turn, oxygen
titration by repeated walking tests or by repeated
constant work-rate tests spends time and it requires the
repetition of several exercise tests in the same day or in
successive days, which may limit the tolerance of hypox-
emic patients with very severe COPD. For this reason and
as an alternative to oxygen flow titration, we propose
a single exercise test at a constant work-rate for all
patients.
Monitoring SpO2 during ADL is extremely important in
order to ensure proper oxygen flow titration. However, the
impact of several methods for prescribing supplemental
oxygen during exercise on daily saturation profile remains
to be studied. For this reason, we have designed this
study to compare the adequacy of several oxygen
titration procedures during exercise in maintaining
a SpO2 > 90% during the ADL in patients with very severe
COPD.Patients and methods
Patients
We randomly selected 31 patients (24 males and 7 females)
from the group of COPD patients undergoing LTOT with
liquid oxygen at the Hospital Universitario La Paz, Madrid,
Spain. Patients met the GOLD criteria6 for very severe COPD
and were clinically stable without exacerbations requiring
hospitalization, administration of antibiotics or increased
doses of steroids during the preceding 2 months. All
patients had been prescribed LTOT by his/her physician at
least six months earlier and in accordance with Spanish
national criteria (patients with exercise dyspnea and an
active life-style with a documented PaO2  55 mmHg or
SpO2  88% during exercise).16 Subjects with unstable
angina, in therapy with mechanical ventilation or trans-
tracheal oxygen or with any locomotive disability that may
have limited exercise tolerance were excluded. Finally, any
change in symptoms or in treatment during the study period
was considered an exit criterion. The study was approved
by the institutional ethics committee and each participant
gave written informed consent.Procedures
The study was carried out on four consecutive days. On the
first day, arterial blood gas values breathing room air were
measured (Rapidpoint 405, Bayer, Munich, Germany) and
a post-bronchodilator spirometry was also performed
(MasterScope, Vyasis, Wu¨rtzburg, Germany).17,18 Patients
performed two 6-min walk tests following ATS guidelines19
while breathing room air. A straight, level corridor
measuring 39.5 m long was used and SpO2 was continuously
measured by a portable pulse oximeter (Pulsox-3iA, Konika
Minolta, Osaka, Japan). A symptom-limited incremental
exercise test was conducted on a cycle-ergometer in
accordance with ATS/ACCP standards,20 as previously
described.21 The workload was increased by 15 W/min
while expired gases, ventilation and electrocardiogram
were continuously measured (Oxycon Alpha, Jaeger).
Exercise oxygen prescription
Oxygen dosing studies were performed in the morning on
three consecutive days, and their order was randomly
allocated. The patients continued to use their medication
according to their usual schedule, and oxygen was supplied
from a Companion 1000 portable liquid oxygen pack (Air-
Products, Madrid, Spain: weight full 2.54 kg) through nasal
prongs, similar to the equipment used by the patients in
their homes.
Further 6-min walk tests were performed with
a progressive increase of oxygen flow rates, until the target
SpO2 > 90% was reached for at least 90% of the test. During
the walk, an oxygen flow of 1 l$min1 above the resting
prescription was used. In the subsequent tests, oxygen flow
rates were increased following a previously-published
protocol.22 Thus, if the SpO2 in the preceding 6-min walk
test had been: 1) 86e90%, in the successive test the
increment was 1 l$min1; 2) 81e85%, the increment was
1546 R. Galera et al.2 l$min1; and 3) <80%, the increment was 3 l$min1.
Patients rested for 20 min between each walking test.
Another day, the oxygen titration was carried out with
successive constant work-rate tests on a cycle ergometer
(Ergobex, Bexen, Spain). After patients performed 1 min of
“unloaded” pedaling, the work-rate was increased to
correspond with an oxygen uptake of 12 ml/min/kg in the
baseline incremental test, and they were encouraged to
maintain a pedaling rate of 50e60 revolutions per minute
(rpm) for 4 min. The choice of 12 mlO2/Kg/min was based
on the metabolic demand required by physical exercise of
light-moderate intensity, which is most common in patients
with very severe COPD. Five patients with severe ventila-
tory limitation to exercise did not reach the target oxygen
uptake during the initial incremental cardiopulmonary
exercise test. In such cases, the workload selected was the
highest level reached on the incremental test, since it has
been demonstrated that such patients can sustain exercise
at levels approaching maximum exercise tolerance.23
Oxygen flow was considered adequate when the SpO2 was
>90% for >90% of the test. The criteria for altering oxygen
flow in the successive tests were identical to the walking
test and the patients rested for 20 min between tests.
On a third day, oxygen flow prescription was evaluated
using a simplified procedure. Patients performed a constant
work-rate test on the cycle ergometer at 40 W or at the
highest, symptom-limited level the patient could tolerate
for 5 min with a pedaling rate from 50 to 60 rpm. As in
a previous study,13 a workload of 40 W was an effort level
equivalent to an oxygen uptake of 12 ml/kg/min in many
very severe COPD patients, so we chose this work intensity.
SpO2 was continuously measured and oxygen flow was
increased every 30 s. If the SpO2 was <80%, the flow was
increased by 3 l$min1; if SpO2 was between 80 and 84%,
the flow was increased by 2 l$min1; and if the range was
85e89%, the flow was increased by 1 l$min1, until the
patients maintained SpO2>90% for at least 2 min.
Ambulatory pulse oximetry during activities of daily
living
One to two weeks after, ambulatory pulse oximeter moni-
toring was performed on four consecutive days. Each day,
patients were asked to continuously breathe oxygen at the
flow prescribed at rest and to randomly increase the oxygen
flow during exercise according the four prescription
methods: 1 l$min1 above the resting prescription, or
oxygen flows established by walking tests, constant exer-
cise tests or simplified constant exercise test.
Assessment took place 12 h per day (from the moment
the patient woke up until 12 h afterward) with the same
pulse oximeter used for the exercise tests. Close attention
was paid to properly set the oxygen-sensing device in place
on the finger of the patient to ensure stable recording. The
digital probe was attached to the left hand for right-handed
patients and to the right hand for left-handed patients.
Patients were asked to maintain their usual physical
activity level and not to sleep during the recording. While
being monitored, patients kept a record of activities and
noteworthy events and specified their duration. The
recorded data were analyzed using computer software (DS-
5, Konica Minolta) and the following measurements were
obtained: mean SpO2, median SpO2, lowest SpO2, thepercentages of total recording time spent SpO2 <90%, 85%,
80% and 70% (CT90%, CT85%, CT80% and CT70%, respec-
tively). The primary outcome parameter was the
percentage of time spent at oxygen saturation lower than
90% (CT90%).
Statistical analysis
Values are expressed as mean  SD or percentage.
Comparisons of the data obtained from oximetry recordings
were made using ANOVA with Bonferroni post-hoc tests.
The relationships between variables and prescribed oxygen
flow were evaluated using Pearson’s correlation and
a stepwise multiple linear regression analysis.
Statistical significance was assumed for p < 0.05. All
analyses were performed using the Statistical Package for
the Social Sciences, version 13.0 software (SPSS Inc., Chi-
cago, IL, USA).
Results
The general characteristics, pulmonary function, and
exercise response parameters of the COPD patients
included in the study are shown in Table 1. Twenty-five
patients had a resting PaO2 < 55 mmHg and the remaining
six had a resting PaO2 < 60 mmHg with evidence of
pulmonary hypertension (2 cases), congestive heart failure
(4 cases) and polycythemia (2 cases). The mean oxygen flow
prescribed at rest was 1.8 l$min1. Airflow limitation was
severe to very severe in all patients, and the peak oxygen
uptake was below 12 ml/min/kg in six subjects. Only one
patient stopped the incremental cardio-pulmonary exercise
before reaching 45 W of work-rate.
Although the exercise oxygen flow prescribed according
to the NOTT recommendations and by successive walking
tests was similar, it was clearly lower than what was esti-
mated by constant exercise tests at a work-rate equivalent
to 12 ml/min/kg of oxygen uptake (Table 2). Fig. 1 shows
the individual distribution of oxygen-flows established for
the four evaluated titration procedures in all the study
patients. As can be observed, oxygen flow during exercise
estimated by the simplified test was slightly lower than the
titration by oxygen uptake, although higher than the other
two procedures.
All of the thirty-one patients completed the evaluation.
The most frequent activities were walking and activities at
home and no differences in either their frequency or
duration were noted over the course of the four days of the
ambulatory SpO2 recording. The ambulatory oximetry
profile during activities of daily living for the oxygen flow
estimated by the four methods is show in Table 2. Although
the four titration methods achieve a mean SpO2 higher 90%
during the 12-h recording period, notable differences
between them can be seen. The time spent SpO2 < 90% is
much higher for the first two methods (NOTT guidelines and
walking tests) than for the constant work-rate tests at an
exercise level equivalent to 12 mlO2/kg/min. Thus, the
prescribed oxygen flow does not maintain a SpO2 > 90% for
any more than 80% of the recording time. Between these
three methods, differences in other SpO2 levels are also
found.
Table 1 General characteristics of COPD patients.
Men/women, n 24/7
Age, yr 64  5
Weight, Kg 67  9
Height, cm 162  7
BMI, Kg/m2 25.6  2.5
Smoking habit, n (%)
Current smokers 7 (23%)
Ex-smokers 23 (74%)
Nonsmokers 1 (3%)
MRC 3.0  0.5
Current treatment, n (%)
SABA 31 (100%)
LABA 27 (87%)
LAMA 26 (84%)
Inhaled corticosteroids 25 (81%)
Theophyllines 11 (36%)
NAC 16 (52%)
Oxygen flow rate at rest, l$min1 1.76  0.41
Post-bronchodilator FVC, l 2.16  0.55
Post-bronchodilator FVC, % predicted 68  11
Post-bronchodilator FEV1, l 0.86  0.21
Post-bronchodilator FEV1, % predicted 34  7
Post-bronchodilator FEV1/FVC, % 40.9  10.3
pH 7.39  0.05
Rest PaO2, mmHg 50.2  5.0
Rest PaCO2, mmHg 45.3  4.4
AaO2, mmHg 32.4  6.6
6-min walk test distance, m 284  87
Baseline SpO2, % 87  2
Minimum SpO2, % 80  4
BODE index 5.8  1.3
ADO index 5.6  1.1
W peak, w 56  20
VE peak, l/min 36.9  7.4
HRR, min1 36  14
V’O2 peak, ml/min/kg 16.6  4.5
Anaerobic threshold, %V’O2max 46.8  11.9
Abbreviations: BMI Z body mass index; MRC Z Medical
Research Council dyspnea scale; SABA Z short-acting beta-
adrenergic agonists; LABA Z long-acting beta-adrenergic
agonists; LAMA Z long-acting muscarinic antagonist;
NAC Z N-acetylcysteine; FVC Z forced vital
capacity;FEV1 Z forced expiratory volume in 1 s;
PaO2 Z oxygen arterial pressure; PaCO2 Z carbon dioxide
arterial pressure; AaO2 Z alveolar-arterial oxygen gradient;
SpO2 Z oxyhemoglobin saturation; W Z work intensity;
VE Z minute ventilation; HRR Z heart rate reserve;
V’O2 Z oxygen uptake.
Oxygen flow in exercise 1547As for oxygen flow titration based on oxygen uptake, the
simplified procedure generates higher values of CT90% and
CT85%. Nevertheless, it reaches SpO2 > 90% for more than
90% of the recording time (Table 2). No differences were
detected between the two procedures for mean SpO2,
lowest SpO2, CT80% or CT70%.
Table 3 shows the ambulatory oximetry profiles for the
several oxygen flow titration procedures as the presence or
absence of hypercapnia. In both subgroups, it is confirmed
that the time spent at SpO2 < 90% was higher for the
titration by the NOTT guidelines or walking tests than forthe oxygen flow titration based on oxygen uptake or by the
simplified procedure. No significant differences were found
between the two subgroups of COPD patients.
Finally, we identified a weak relationship between age
and the oxygen flows established by the NOTT guidelines
(r Z 0.690, p < 0.001), walking tests (r Z 0.50,
p Z 0.004) and constant work-rate exercise tests at
12 mlO2/Kg/min (rZ 0.369, pZ 0.041). However, from the
evaluated clinical and functional parameters, it was not
possible to develop accurate equations to predict the
oxygen flow during exercise in COPD patients.Discussion
Our results show that oxygen flow titration during exercise
using the NOTT guidelines or by repetition of 6-min walk
tests does not guarantee the desired level of oxygenation
(SpO2 > 90%) for more than 20% of the daily lives of COPD
patients. Titration by means of constant work-rate tests
with a level of exercise equivalent to an oxygen uptake of
12 ml/min/kg requires higher oxygen flows but maintains
a more satisfactory level of oxygenation. As an alternative,
titration with a single, simplified exercise test with
a constant load at 40 W establishes slightly lower oxygen
flow and daytime saturation, although it is able to maintain
SpO2 > 90% for more than 90% of the day.
Although it would seem desirable to be as precise as
possible in correcting exercise desaturation in patients
already on LTOT,22 the impact of the several titration
methods remains to be studied. The need for the present
study was called for in an NHLBI Workshop Report recom-
mending clinical trials in subjects with COPD centered on
the effectiveness of activity-dependent prescription for O2
flow rate based on clinical tests performed at rest and
during exercise.24
It has been shown that the 6-min walk test is even more
sensitive in detecting desaturation than maximal or
submaximal tests using cycle ergometers.8 However, there
are several factors that may be sources of variation in the
distances walked and, therefore, in the amount of exertion
during oxygen flow titration.10,11 Although the walk test,
when correctly administered, is considered a method for
evaluating a patient’s daily activity,25 this may not be the
case in patients with COPD and severe hypoxemia at rest. In
this instance, titration based on the oxygen consumption
required by the intensity of the physical activity that is
usually performed by COPD patients with LTOT seems to be
a more adequate approximation. In our case, we estimate
the intensity of the exercise done by these patients by using
the Compendium of Physical Activities,15 which standard-
izes subjective measurements by assigning oxygen uptake
values for over 600 activities, allowing researchers to
compare data across studies.15 The choice of 12 ml O2/kg/
min is based on the demand required by tasks such as
walking 3.0 mph (1.34 m/s on a level, firm surface and at
a moderate pace), housework (sweeping, vacuuming,
mopping), gardening (trimming the lawn) and going up/
down stairs. All these activities entail physical exercise of
light-moderate intensity, which is most common in patients
with very severe COPD.12
Table 2 Ambulatory oximetry profile during activities of daily living for each mode of oxygen flow titration.
Titration mode NOTT guidelines 6-min walk tests Constant work-rate
tests (work-rate equivalent
at 12 mlO2/Kg/min)
Simplified constant
test (at 40 w)
Oxygen flow, l$min1 2.7  0.5 2.7  0.4 4.3  0.7 *zx 3.8  0.7 *z
Mean SpO2, % 91.3  2.8 92.2  2.2 94.6  2.2 *‼ 94.4  2.6 *‼
Median SpO2, % 92.1  2.6 93.3  2.3 95.2  1.8 *‼ 94.6  2.2 *
Lowest SpO2, % 72.6  10.3 74.2  9.1 82.3  8.2 *‼ 77.4  8.3
CT90%, % 22.1  18.7 20.8  19.5 6.7  12.7 *z{ 7.9  12.3 *z
CT85%, % 6.7  5.4 5.9  4.9 1.6  3.1 *zx 2.0  3.0 *z
CT80%, % 3.4  3.7 2.9  3.1 0.9  2.2 y‼ 1.0  2.1 y‼
CT70%, % 0.6  0.9 0.1  0.1 y 0.1  0.3 y 0.1  0.3 y
Abbreviations: SpO2Z oxyhemoglobin saturation; CT90% to CT70%Z time spent SpO2 <90% to <70%, respectively; NOTTZ Nocturnal
Oxygen Therapy Trial Group.
Comparisons between groups by the post-hoc Bonferroni test.
versus NOTT guidelines: *p < 0.001; yp < 0.05.
versus 6-min walk tests: zp < 0.001; ‼ p < 0.01.
versus simplified constant test: xp < 0.01; {p < 0.05.
1548 R. Galera et al.Despite the fact that titration based on a certain level of
oxygen consumption provides the best results, COPD
patients still spend a small percentage of time with
SpO2 < 90%. Aside from the possible problems in SpO2
measurement, the variability in FiO2 provided by the nasal
cannula26 or potential technical errors in the handling of
the liquid oxygen, it is possible that at some moment the
physical activity surpasses the oxygen requirement esti-
mated in the titration. This finding could also be justified by
desaturations during housework, which the patient may not
interpret as exercise and therefore not increase the oxygen
flow. In fact, in COPD patients, transient desaturation has
been reported during such simple activities as eating,
talking, watching TV or washing, even in the absence of
marked resting hypoxemia.14
Although the nonexistence of a gold standard to
compare the various protocols analyzed makes it difficult to
establish a recommendation on the most suitable titration
method, the percentage of time with an SpO2 < 90% duringFigure 1 Comparison of the oxygen flow prescribed during
exercise by the different titration methods. NOTTZ Nocturnal
Oxygen Therapy Trial.daily life activities probably constitutes the best alterna-
tive since it corresponds to the therapeutic goal for LTOT.5
In our case, we limit the pulse oximeter monitoring to the
first 12 h of daily activity to homogenize the measurement
and to avoid the influence of sleep periods, which probably
need another titration procedure and are not considered in
our patients. Moreover, the activity profiles of severe COPD
patients reflect that the biggest intensity develops during
12 h after getting up.12e15
With the aim of saving time required for constant work-
rate tests at different flows and the resting periods
between tests, and in order to minimize the exertion and
inconvenience that these tests cause patients, we have
proposed an alternative titration procedure that requires
a single exercise test. In doing so, we chose a setting of
40 W as this is the workload that is closest to the level of
effort necessary to reach 12 mlO2/kg/min in most patients.
In addition, we have verified that this is a well-tolerated
exercise intensity that is accessible to the majority of
patients with COPD and LTOT. In fact, in only one of our
patients was it necessary to use a slightly lower workload
(30 W), so that the patient could maintain the exercise for
5 min.
One consideration that can be seen in our results is the
need to use high oxygen flows during exercise in order to
maintain proper saturation. In fact, it is well-known that
oxygen tolerance has an oxygen flow-dependent behavior.27
Patients with severe COPD felt less dyspneic and exercised
longer while receiving humidified high-flow oxygen
compared to low-flow oxygen delivery.28 High oxygen flows
are able to reduce minute ventilation and the respiratory
rate for a given workload, improve ventilatory muscle
function during exercise by postponing the onset of respi-
ratory muscle fatigue and improving the capacity of the
diaphragm to sustain work, increase oxygen delivery and its
utilization by muscles during exercise, decrease dyspnea
and improve endurance by directly reducing chemore-
ceptor activity.3 Furthermore, it has been confirmed that
hyperoxia reduces dynamic hyperinflation,29 which is the
main limiting factor of daily physical activity in COPD
patients.13
Table 3 Ambulatory oximetry profile during activities of daily living for each mode of oxygen flow titration in COPD patients
with or without hypercapnia.
Titration
mode
Non-hypercapnic COPD patients (n Z 16) Hypercapnic COPD patients (n Z 15)
NOTT
guidelines
6-min
walk tests
Constant
work-rate
tests
Simplified
constant test
NOTT
guidelines
6-min
walk tests
Constant
work-rate
tests
Simplified
constant test
Oxygen flow,
l$min1
2.7  0.6 2.7  0.4 4.4  0.7 *z 3.9  0.7 $z 2.7  0.3 2.7  0.4 4.3  0.8 *z 3.7  0.7 $z
Mean
SpO2, %
91.5  2.5 92.1  2.2 y 94.7  2.3 $‼ 94.5  2.6 $‼ 91.2  3.1 92.3  2.2 94.5  2.3 $# 94.3  2.6 $#
Median
SpO2, %
92.3  2.6 93.1  2.3 95.1  1.9 y# 94.6  2.2 91.8  2.6 93.4  2.4 y 95.3  1.9 y 94.7  2.3 $#
Lowest
SpO2, %
72.1  9.8 73.5  9.0 81.6  8.7 y# 76.9  8.1 y{ 73.1  11.1 75.1  9.4 83.2  7.8 y# 77.9  8.8 y
CT90%, % 23.6  19.4 22.6  20.5 7.7  13.6 *z 9.0  13.1 *z 20.6  18.5 19.0  18.9 5.6  12.0 $z 6.7  11.7 $‼
CT85%, % 7.4  5.4 6.8  5.2 1.6  3.1 $z 2.1  2.9 $‼ 6.1  5.5 5.1  4.8 1.5  3.3 y‼ 1.8  3.2 y#
CT80%, % 3.5  3.8 3.1  3.2 1.1  2.3 1.1  2.3 3.3  3.8 2.7  3.1 0.8  2.0 0.9  2.0
CT70%, % 0.6  0.8 0.1  0.1 0.1  0.3 # 0.1  0.3 #x 0.7  0.9 0.1  0.1 0.1  0.2 # 0.1  0.2 #x
Abbreviations: SpO2Z oxyhemoglobin saturation; CT90% to CT70%Z time spent SpO2 <90% to <70%, respectively; NOTTZ Nocturnal
Oxygen Therapy Trial Group.
Comparisons between groups by the post-hoc Bonferroni test.
versus NOTT guidelines: *p < 0.001; $ p < 0.01; yp < 0.05.
versus 6-min walk tests: zp < 0.001; ‼ p < 0.01; #p < 0.05.
versus simplified constant test: xp < 0.01; {p < 0.05.
Oxygen flow in exercise 1549An attractive alternative to oxygen-flow titration
procedures might consist of the integration of sensors in the
portable oxygen devices that would measure oxyhemo-
globin saturation in real time and adjust the oxygen flow
until reaching over 90% saturation levels at every moment
and for each activity. Nevertheless, this technical devel-
opment is still being prepared, and it would be necessary to
evaluate its validity and cost-effectiveness.
Several possible limitations of our study merit comment.
First, our observations were based on a small number of
patients from a single hospital, and it is unclear whether our
results can be extrapolated to the entire population of COPD
patients. Second, we have not monitored the oxygen flow
used by the patients over the course of the entire day. In
following a procedure quite similar to clinical practice, we
have merely given the patients indications for the oxygen
flows that they should be using at rest and during exercise
each day of the study. Third, oxygen supplementation during
exercise was done in all our patients with liquid oxygen;
therefore, we do not have any information on the impact of
the titration methods in patients who use portable concen-
trators. Nevertheless, we consider that the results could be
similar, as the effectiveness of oxygen supplementation from
a portable oxygen concentrator did not differ from the liquid
oxygen source during the 6’WT in COPD patients with respi-
ratory failure.30 And fourth, although our results show that
titration by means of oxygen uptake or by the simplified
procedure are more effective for reaching the desired SpO2
level during exercise, they do not provide information about
the progression of COPD or on survival.
In conclusion, our study shows that the titration of
oxygen flow during exercise by NOTT guidelines or even by
walking tests does not provide adequate correction of
oxygenation during ADLs in patients with COPD who are
receiving LTOT. Contrarily, an alternative titration methodbased on exercise tests at a constant work-rate equivalent
to 12 ml/min/kg of oxygen uptake prescribes higher oxygen
flows, which provide better correction of daytime SpO2.
Titration using a simplified procedure with a single test
could be considered an alternative, especially in situations
of resource or time limitations and poor tolerance by
patients.Conflict of interest
None declared.References
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